top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

[...]the effect of mTOR inhibition on TF activity and thrombus formation in vivo has not yet been studied. [...]it is unclear whether second-generation DES substances everolimus and zotarolimus have ...

European Heart Journal, Camici, Giovanni G., Steffel, Jan, Amanovic, Ilijana, Breitenstein, Alexander, Baldinger, Janette, Keller, Stephan, Lüscher, Thomas F., Tanner, Felix C.

Date : 01/01/2010 Item size : 307054 bytes
Ehjcardiovascrec

Abstract Aims The mammalian silent information regulator-two 1 (Sirt1) blunts the noxious effects of cardiovascular risk factors such as type 2 diabetes mellitus and obesity. In vivo, mice treated ...

Cardiovascular Research, Breitenstein, Alexander, Stein, Sokrates, Holy, Erik W., Camici, Giovanni G., Lohmann, Christine, Akhmedov, Alexander, Spescha, Remo, Elliott, Peter J., Westphal, Christoph ...

Date : 01/02/2011 Item size : 348283 bytes
Ehjournal

[...]the effect of mTOR inhibition on TF activity and thrombus formation in vivo has not yet been studied. [...]it is unclear whether second-generation DES substances everolimus and zotarolimus have ...

European Heart Journal, Camici, Giovanni G., Steffel, Jan, Amanovic, Ilijana, Breitenstein, Alexander, Baldinger, Janette, Keller, Stephan, Lüscher, Thomas F., Tanner, Felix C.

Date : 01/01/2010 Item size : 297484 bytes
Ehjcardiovascrec

Abstract Aims The mammalian silent information regulator-two 1 (Sirt1) blunts the noxious effects of cardiovascular risk factors such as type 2 diabetes mellitus and obesity. In vivo, mice treated ...

Cardiovascular Research, Breitenstein, Alexander, Stein, Sokrates, Holy, Erik W., Camici, Giovanni G., Lohmann, Christine, Akhmedov, Alexander, Spescha, Remo, Elliott, Peter J., Westphal, Christoph ...

Date : 01/02/2011 Item size : 345868 bytes